Clinical trial registry record

Metformin Safety and Efficacy in Osteoarthritis.

A registered PHASE3 study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Recruiting.
Evidence
Registered phase 3 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated March 13, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT06231758
Last registry update
March 13, 2026
Status
Recruiting
Phase
Phase 3
Sponsor
Mostafa Bahaa
Enrollment
70
Countries
Egypt
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE3 study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 3
Study design
RANDOMIZED · PARALLEL · TREATMENT · DOUBLE
Evidence population
Human clinical study registration
Participants
70
Population
ALL · 30 Years to 60 Years
Duration
2024-01-30 to 2027-11-20
Intervention
Celecoxib 200mg; Metformin
Comparator
control group; Comparative group
Outcomes measured
The primary efficacy end point will be the change of Visual Analogue Scale (VAS) pain score from baseline to post treat…; Secondary Outcome Measures will be the change of WOMAC Osteoarthritis Index from baseline to posttreatment — 3 months
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 3A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Metformin · 100%Title contains controlled topic terminology. Source terminology contains a controlled topic term.

Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.

metformin
Read the original source →Export JSON